Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PLD vs DNR in Adult ALL
NCT02070523Phase 3Unknown
- Sponsor
- Changzhou Jinyuan Pharmaceutical Manufacturing
- Start
- Dec 2013
- Primary completion
- Nov 2015
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of doxorubicin in acute lymphoblastic leukemia (ALL), sponsored by Changzhou Jinyuan Pharmaceutical Manufacturing. Status: unknown.
02
Drugs
doxorubicin
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT02070523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02070523.